Micafungin (CAS 235114-32-6)
QUICK LINKS
Micafungin is an echinocandin class antifungal compound that is studied for its mechanism of action and its role in combating fungal pathogens. It is often used in research to investigate the biosynthesis and inhibition of fungal cell wall components, primarily by inhibiting the enzyme 1,3-β-D-glucan synthase, which is for cell wall formation in many fungi. This focus on enzyme inhibition is important in understanding how to control fungal growth and proliferation. Micafungin also serves as a reference compound in the development of new analytical methods for detecting and quantifying the presence of antifungal agents in various biological and environmental samples. In addition, research involving micafungin may include studies on the genetics of fungal resistance, helping to elucidate how resistance to echinocandin-class compounds develops and spreads among pathogenic fungal populations.
Micafungin (CAS 235114-32-6) References
- Micafungin: the US perspective. | Zaas, AK. and Steinbach, WJ. 2005. Expert Rev Anti Infect Ther. 3: 183-90. PMID: 15918776
- Micafungin in pediatrics: when one size does not fit all. | Ashouri, N., et al. 2008. Expert Opin Drug Metab Toxicol. 4: 463-9. PMID: 18433348
- Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients. | Lehrnbecher, T. and Groll, AH. 2010. Pediatr Blood Cancer. 55: 229-32. PMID: 20583216
- Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature. | Tascini, C., et al. 2013. Mycopathologia. 175: 129-34. PMID: 23073824
- Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections. | Scott, LJ. 2012. Drugs. 72: 2141-65. PMID: 23083111
- Micafungin for the treatment of invasive aspergillosis. | Enoch, DA., et al. 2014. J Infect. 68: 507-26. PMID: 24480373
- Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials. | Manzoni, P., et al. 2014. Pediatr Infect Dis J. 33: e291-8. PMID: 24892849
- Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. | Wasmann, RE., et al. 2018. Clin Pharmacokinet. 57: 267-286. PMID: 28791666
- Micafungin-Induced Hypoglycemia in a Patient With Type 1 Diabetes: A Case Report and Review of Literature. | Morkos, M., et al. 2019. J Clin Endocrinol Metab. 104: 981-984. PMID: 30398618
- Biological Properties and Analytical Methods for Micafungin: A Critical Review. | Marena, GD., et al. 2021. Crit Rev Anal Chem. 51: 312-328. PMID: 32064916
- Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age. | Abdel-Haq, N., et al. 2022. Expert Rev Anti Infect Ther. 20: 493-505. PMID: 34882043
- Micafungin and amphotericin B synergy against Candida auris. | Jaggavarapu, S., et al. 2020. Lancet Microbe. 1: e314-e315. PMID: 35544183
- An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old. | Bassetti, M., et al. 2022. Expert Opin Pharmacother. 23: 1987-1993. PMID: 36373395
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Micafungin, 1 mg | sc-391640 | 1 mg | $286.00 |